145 related articles for article (PubMed ID: 21469768)
1. Breast cancer anti-estrogen resistance protein 1 (BCAR1/p130cas) in pulmonary disease tissue and serum.
Deng B; Huang W; Tan QY; Fan XQ; Jiang YG; Liu L; Zhong YY; Liang YG; Wang RW
Mol Diagn Ther; 2011 Feb; 15(1):31-40. PubMed ID: 21469768
[TBL] [Abstract][Full Text] [Related]
2. Increased BCAR1 predicts poor outcomes of non-small cell lung cancer in multiple-center patients.
Deng B; Sun Z; Jason W; Yang P
Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S701-8. PubMed ID: 23904007
[TBL] [Abstract][Full Text] [Related]
3. Expression of breast cancer anti-estrogen resistance 1 in relation to vascular endothelial growth factor, p53, and prognosis in esophageal squamous cell cancer.
Huang W; Deng B; Wang RW; Tan QY; Jiang YG
Dis Esophagus; 2013 Jul; 26(5):528-37. PubMed ID: 22816673
[TBL] [Abstract][Full Text] [Related]
4. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
5. CYFRA 21-1 enzyme-linked immunosorbent assay. Evaluation as a tumor marker in non-small cell lung cancer.
Lai RS; Hsu HK; Lu JY; Ger LP; Lai NS
Chest; 1996 Apr; 109(4):995-1000. PubMed ID: 8635383
[TBL] [Abstract][Full Text] [Related]
6. BCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancer.
Huang W; Deng B; Wang RW; Tan QY; He Y; Jiang YG; Zhou JH
PLoS One; 2012; 7(4):e36124. PubMed ID: 22558353
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of the BCAR1/p130Cas protein in non-malignant and malignant human breast tissue.
van der Flier S; van der Kwast TH; Claassen CJ; Timmermans M; Brinkman A; Henzen-Logmans SC; Foekens JA; Dorssers LC
Int J Biol Markers; 2001; 16(3):172-8. PubMed ID: 11605729
[TBL] [Abstract][Full Text] [Related]
8. Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment.
van der Flier S; Brinkman A; Look MP; Kok EM; Meijer-van Gelder ME; Klijn JG; Dorssers LC; Foekens JA
J Natl Cancer Inst; 2000 Jan; 92(2):120-7. PubMed ID: 10639513
[TBL] [Abstract][Full Text] [Related]
9. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer.
Heumann A; Heinemann N; Hube-Magg C; Lang DS; Grupp K; Kluth M; Minner S; Möller-Koop C; Graefen M; Heinzer H; Tsourlakis MC; Wilczak W; Wittmer C; Jacobsen F; Huland H; Simon R; Schlomm T; Sauter G; Steurer S; Lebok P; Hinsch A
BMC Cancer; 2018 Jan; 18(1):37. PubMed ID: 29304771
[TBL] [Abstract][Full Text] [Related]
10. Development of an ELISA for measurement of BCAR1 protein in human breast cancer tissue.
Grebenchtchikov N; Brinkman A; van Broekhoven SP; de Jong D; Geurts-Moespot A; Span PN; Peters HA; Portengen H; Foekens JA; Sweep CG; Dorssers LC
Clin Chem; 2004 Aug; 50(8):1356-63. PubMed ID: 15277346
[TBL] [Abstract][Full Text] [Related]
11. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive immunohistochemical analysis of RET, BCAR1, and BCAR3 expression in patients with Luminal A and B breast cancer subtypes.
Pavanelli AC; Mangone FR; Yoganathan P; Bessa SA; Nonogaki S; de Toledo Osório CAB; de Andrade VP; Soares IC; de Mello ES; Mulligan LM; Nagai MA
Breast Cancer Res Treat; 2022 Feb; 192(1):43-52. PubMed ID: 35031902
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of BCAR1 in patients with primary breast cancer.
Dorssers LC; Grebenchtchikov N; Brinkman A; Look MP; van Broekhoven SP; de Jong D; Peters HA; Portengen H; Meijer-van Gelder ME; Klijn JG; van Tienoven DT; Geurts-Moespot A; Span PN; Foekens JA; Sweep FC
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6194-202. PubMed ID: 15448007
[TBL] [Abstract][Full Text] [Related]
14. BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas.
van der Flier S; Chan CM; Brinkman A; Smid M; Johnston SR; Dorssers LC; Dowsett M
Int J Cancer; 2000 Sep; 89(5):465-8. PubMed ID: 11008210
[TBL] [Abstract][Full Text] [Related]
15. Serum VEGF levels in the early diagnosis and severity assessment of non-small cell lung cancer.
Lai Y; Wang X; Zeng T; Xing S; Dai S; Wang J; Chen S; Li X; Xie Y; Zhu Y; Liu W
J Cancer; 2018; 9(9):1538-1547. PubMed ID: 29760791
[No Abstract] [Full Text] [Related]
16. Combined detection of estrogen and tumor markers is an important reference factor in the diagnosis and prognosis of lung cancer.
Bai Y; Shen W; Zhu M; Zhang L; Wei Y; Tang H; Zhao J
J Cell Biochem; 2019 Jan; 120(1):105-114. PubMed ID: 30216488
[TBL] [Abstract][Full Text] [Related]
17. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
[TBL] [Abstract][Full Text] [Related]
18. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
Jiang AG; Chen HL; Lu HY
BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
[TBL] [Abstract][Full Text] [Related]
19. BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A.
Mao CG; Jiang SS; Shen C; Long T; Jin H; Tan QY; Deng B
Thorac Cancer; 2020 Nov; 11(11):3326-3336. PubMed ID: 33001583
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
